Silicom (SILC) faces declining sales and missed tech shifts, leaving it unprofitable and trading near liquidation value.

Eos posts explosive Q2 growth, a $19B pipeline, and benefits from federal support, despite modest dilution and high valuation ...

Prescription digital therapeutics (PDTs) are FDA-regulated tools that deliver evidence-based interventions via software, and ...

Lightroom Classic may be the 'old' Lightroom, but don't be fooled by the name – it's still right up there with the latest ...